title: Zoledronate, fractures, and mortality after hip fracture.
authors.forename: Cesar A
authors.initials: CA
authors.lastname: Lopez
authors.forename: Zahra
authors.initials: Z
authors.lastname: Tasneem
mesh_terms: D001281:Atrial Fibrillation / Q000139:chemically induced; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D015986:Confounding Factors, Epidemiologic; D004164:Diphosphonates / Q000627:therapeutic use*; D050723:Fractures, Bone / Q000517:prevention & control*; D006620:Hip Fractures / Q000401:mortality; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid